BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 24, 2010
View Archived Issues
EVX-001688 improves spatial memory in young and aged rats
Read More
Phase Ia trial demonstrates safety of SGN-70 in healthy subjects
Read More
GRN-529 has antidepressant, anxiolytic and analgesic effects in vivo
Read More
Boehringer Ingelheim describes novel mTOR inhibitors
Read More
FDA clears Advanced Cell Technology's phase I/II RPE trial
Read More
NeuroSearch claims new activators of voltage-gated K(V)7.2/3 potassium channel
Read More
SkyePharma advances two phase III trials of asthma candidate Flutiform in Japan
Read More
BMS-582949 shows promise to treat rheumatoid arthritis
Read More
LCZ-696 is well tolerated by patients with chronic stable heart failure in phase II trial
Read More
First-in-human data disclosed on dual PI3K/mTOR inhibitors PF-05212384 and PF-04691502
Read More
FG-4592 is safe and increases hemoglobin levels in CKD-related anemia
Read More
Roche to develop diagnostic tests to detect EGFR mutations in lung cancer
Read More
Abbott patents new serotonin 5-HT2C receptor agonists
Read More
Pivotal phase III trial of IPX-066 in early PD meets primary endpoint
Read More
Baxter and Archemix enter into agreements covering hemophilia-related assets
Read More
GW and Otsuka Pharma begin phase III cancer pain program for Sativex
Read More
Achaogen claims novel carbacephem beta-lactam antibiotics
Read More
GlaxoSmithKline discloses new orexin receptor antagonists
Read More
CEL-SCI completes global investigator meeting on phase III Multikine trial
Read More
Gilead submits NDA to FDA for single-tablet Truvada/TMC-278 combination
Read More
Vertex Pharma submits NDA to FDA for telaprevir in hepatitis C
Read More
FDA approves testosterone replacement therapy Axiron
Read More
Grifols launches Flebogamma 10% DIF in U.S.
Read More
SIRS-Lab and Pfizer collaborate on diagnostic tests to benefit patients with sepsis
Read More
Gablofen injection approved in U.S. for severe spasticity
Read More
